Obstructive sleep apnea can run in families, and genetic differences contribute to its risk. Common OSA is not usually inherited through one gene, however, and having an affected parent does not mean that a child will develop it.
OSA is a complex phenotype. That means the diagnosis can arise from different combinations of upper-airway anatomy, body-fat distribution, breathing control, airway-muscle responses, age, hormones, health conditions, exposures, and behavior. Relatives may share some of these factors through genes, some through their environment, and some through both.
What does "runs in families" actually mean?
Family aggregation means that a condition or measured trait is more common or more similar among relatives than expected. It does not establish how much of that similarity comes from DNA.
In the original Cleveland Family Study, sleep-disordered breathing was found in 21% of relatives of people with laboratory-confirmed disease, compared with 12% of neighborhood controls. The association persisted after accounting for measured obesity, supporting a familial contribution beyond body size alone 1.
Later analysis of 1,802 people from 310 Cleveland families estimated the heritability of the apnea-hypopnea index at about 33% to 37%, depending on whether it came from a laboratory or home study. It also found substantial overlap between genetic influences on AHI and measures of adiposity 2. This suggests that some inherited susceptibility to OSA is shared with weight and fat-distribution biology, while some is not.
A 2019 study of 71 Hungarian twin pairs produced much higher heritability estimates for AHI and related sleep-study measures. It also found that daytime sleepiness was less genetically influenced than those breathing measures 3. This was a small twin sample with a high prevalence of OSA, so its percentages should not be treated as a universal estimate.
Earlier segregation work also shows why OSA should not be presented as a simple inherited disorder. A study of 584 pedigrees found familial patterns in reported snoring and sleepiness, but it did not find a clear Mendelian pattern for snoring. For its constructed "sleep apnea" symptom phenotype, genetic and non-genetic models could fit the data similarly 4. Snoring plus sleepiness is not the same phenotype as OSA confirmed on a sleep study.
These studies agree on a familial component but not on one inheritance percentage. They measured different populations, ages, symptoms, sleep-study indices, and environments. A heritability estimate describes variation within a studied population. It does not say that a given person's OSA is a certain percentage genetic, nor can it calculate that person's chance of developing the condition 5.
What has genomic research found?
Genome-wide association studies look across many common DNA variants to find statistical associations with a trait. They do not look for one decisive "sleep apnea gene."
A 2023 analysis of 568,576 participants in the US Million Veteran Program found multiple OSA-associated regions and differences in genetic associations by sex. A larger meta-analysis within the same paper included 916,696 people 6. The work supports a polygenic contribution, meaning many variants with small effects may contribute across different biological pathways.
The study also shows the limits of current genomic evidence. OSA was identified largely through electronic health records rather than uniform sleep studies, underdiagnosis can misclassify controls, and the veteran sample was 91% male. The researchers included several ancestry groups, but statistical power was not equal across them. Genetic associations found in one sex, ancestry, healthcare system, or phenotype may not transfer cleanly to another.
A family can also share more than DNA. Relatives may have similar weight patterns, alcohol or tobacco exposure, housing and air quality, sleep schedules, healthcare access, and expectations about which symptoms deserve evaluation. Once one person is diagnosed, other relatives may recognize symptoms and seek testing. Family clustering therefore reflects a mixture of inherited biology, shared circumstances, and diagnostic behavior.
Which inherited traits may contribute?
OSA occurs when the upper airway repeatedly narrows or closes during sleep. Several traits involved in that process can have familial or genetic contributions:
- Craniofacial and upper-airway anatomy: Jaw position, tongue and soft-tissue volume, airway dimensions, and other head and neck features can affect how easily the airway narrows.
- Adiposity and fat distribution: Genetic influences on body weight, neck or tongue fat, and where the body stores fat may overlap with OSA susceptibility.
- Airway-muscle response: People differ in how effectively the muscles around the throat respond when the airway starts to narrow.
- Ventilatory control and arousal traits: The stability of the breathing-control system and how readily someone wakes in response to restricted airflow can contribute to the OSA phenotype.
These are plausible pathways, not a checklist that diagnoses a person. International consensus guidance describes OSA as a multifaceted disorder involving anatomical and non-anatomical traits, with substantial variation between people 7. A person can have a smaller airway without OSA, or develop OSA through a different combination of factors.
This is also why OSA can affect fit people and people who do not match the stereotype of an older man with obesity. Body weight is an important risk factor for many people, but it is not a requirement for airway obstruction during sleep.
AHI, symptoms, and family history are different phenotypes
The apnea-hypopnea index is the average number of scored apneas and hypopneas per hour of sleep. Many genetic studies use AHI because it is measurable, but an AHI is not the whole experience of OSA.
People with similar AHI values can differ in oxygen changes, event duration, sleep-stage or positional pattern, arousals, symptoms, and related health conditions. Definitions used to score hypopneas can also change the resulting AHI and the apparent prevalence of OSA 7. A finding about the genetics of AHI should not automatically be interpreted as a finding about fatigue, sleepiness, cardiovascular effects, or treatment response.
Family history is another kind of information. It can lower the threshold for asking about symptoms and considering an appropriate sleep study, but it cannot diagnose OSA or rule it out. The NHLBI includes family history alongside symptoms and other risk factors in a clinical evaluation 8.
Can a genetic test diagnose common OSA?
Current diagnostic guidance for common OSA relies on clinical evaluation and polysomnography or an appropriate home sleep apnea test, while genomic research reports population-level associations rather than validated diagnostic performance 96. Consumer DNA reports and experimental polygenic scores therefore cannot diagnose common OSA, rule it out, predict its severity, or select its treatment.
The American Academy of Sleep Medicine recommends polysomnography as the standard diagnostic test when an adult's clinical evaluation raises concern for OSA. A technically adequate home sleep apnea test can be used for selected uncomplicated adults at increased risk of moderate to severe OSA. If a single home test is negative, inconclusive, or technically inadequate while concern remains, the guideline recommends polysomnography 9.
Polysomnography and home sleep apnea testing are sleep tests, not genetic tests. Their purpose is to measure the current breathing phenotype. A commercial genetic result should not be used to avoid a sleep evaluation, start PAP, buy an oral appliance, or decide that treatment is unnecessary.
Polygenic scores for OSA remain investigational. Their performance depends on how OSA was defined in the source data and on how well the development population represents the person being assessed 6. Research may eventually identify useful genetic subgroups, but there is no current score that replaces symptoms, examination, and sleep testing.
OSA is not the same as every inherited breathing disorder
The word "sleep apnea" covers distinct conditions:
- Obstructive sleep apnea: Airflow is blocked despite ongoing effort to breathe.
- Central sleep apnea: Breathing pauses occur because the brain's respiratory-control signal is absent or unstable. In adults, common contexts include heart failure, stroke, high altitude, and medicines such as opioids 10.
- Sleep-related hypoventilation: Breathing is persistently insufficient, allowing carbon dioxide to rise. It can occur with obesity, neuromuscular or chest-wall disorders, lung disease, medicines, and rare syndromes 11.
Common adult central sleep apnea should not be assumed to be inherited because it involves breathing control. Congenital central hypoventilation syndrome is a rare and different disorder in which an appropriate clinical phenotype plus a pathogenic variant in PHOX2B establishes the diagnosis 12. That is a genuine setting for specialist genetic testing and counseling. It does not make PHOX2B a test for ordinary snoring or common OSA.
Genetic counseling may also be appropriate when a clinician suspects a known craniofacial, neuromuscular, metabolic, or chromosomal syndrome, or when a pathogenic variant has already been identified in a family. A family history of common OSA by itself does not usually require genetic counseling.
What family history means for children
A parent's OSA does not mean that a child directly inherits the same airway disorder. Childhood OSA has age-specific causes and needs pediatric assessment.
Large tonsils or adenoids and obesity are common pathways in children. Craniofacial differences, neuromuscular disorders, Down syndrome, premature birth, and tobacco-smoke exposure can also increase risk. Nighttime signs can include snoring, mouth breathing, breathing pauses, and frequent waking, while daytime signs may include sleepiness, headaches, attention problems, or behavioral changes 13.
Tell the child's healthcare professional about both the symptoms and family history. The NHLBI advises that a child being evaluated for sleep apnea needs a sleep study to identify the type and severity, along with an examination for tonsillar or other airway obstruction 13. Do not use a parent's diagnosis, PAP data, or consumer genetic result to diagnose the child.
Can you prevent genetically influenced OSA?
No action can guarantee that OSA will never develop. The useful goal is to address modifiable contributors and recognize the current phenotype early, not to overcome a supposedly fixed genetic fate.
Depending on the person, reasonable steps include:
- pursue supportive weight care when weight contributes, without assuming that weight is the only cause
- limit alcohol if it worsens snoring, airway obstruction, or sleep quality
- seek help to stop smoking and reduce secondhand-smoke exposure
- review opioids, sedatives, and other medicines that may affect nighttime breathing with the prescriber
- treat persistent nasal blockage or allergy symptoms with appropriate clinical guidance
- reassess new or worsening symptoms during pregnancy and around menopause, when OSA risk can change 14
- consider sleep position if testing or a clinician identifies a positional pattern
Do not stop a sedative, opioid, or other prescription without the prescriber. These measures may reduce a relevant risk or improve treatment, but none proves that OSA has been prevented. NHLBI guidance includes weight care, limiting alcohol, smoking cessation, and position among supportive approaches, alongside PAP, oral devices, and other treatments when indicated 1015.
When to ask about testing
Discuss OSA with a healthcare professional if you or a child has witnessed breathing pauses, gasping or choking during sleep, habitual disruptive snoring, or persistent daytime impairment. In adults, unrefreshing sleep, morning headache, insomnia, concentration problems, and sleepiness can also be part of the presentation. Not everyone with OSA snores loudly or feels obviously sleepy.
Mention affected relatives, but bring the current symptoms and health context to the center of the evaluation. A clinician can decide whether an in-laboratory study or a home test is appropriate and whether central events, hypoventilation, another sleep disorder, or another medical cause needs consideration 98.
If you feel sleepy while driving, do not drive. Untreated OSA can impair attention and decision-making on the road 16. Arrange another way to travel and seek prompt clinical assessment.
Genetics does not make treatment futile
Treatment is selected according to the OSA you have now: its severity and pattern, symptoms, oxygen changes, anatomy, body weight when relevant, health conditions, treatment preferences, and response over time. Options can include PAP, a custom oral appliance, positional therapy, weight-related care, upper-airway or jaw surgery, tonsil treatment, or another targeted approach 15.
A family history does not prove that one treatment will work, and a genetic predisposition does not mean that therapy cannot work. Current phenotype and follow-up testing, not ancestry or a consumer DNA report, should guide the plan.
